These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39449040)

  • 1. A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancer.
    Qi F; Gao N; Li J; Zhou C; Jiang J; Zhou B; Guo L; Feng X; Ji J; Cai Q; Yang L; Zhu R; Que X; Wu J; Xi W; Qin W; Zhang J
    Mol Cancer; 2024 Oct; 23(1):239. PubMed ID: 39449040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
    Yang M; Guo Y; Liu X; Liu N
    Med Sci Monit; 2020 Sep; 26():e924975. PubMed ID: 32989212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.
    Macartney-Coxson DP; Hood KA; Shi HJ; Ward T; Wiles A; O'Connor R; Hall DA; Lea RA; Royds JA; Stubbs RS; Rooker S
    BMC Cancer; 2008 Jul; 8():187. PubMed ID: 18590575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
    Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.
    Michl M; Taverna F; Kumbrink J; Schiergens TS; Heinemann V; Engel J; Kirchner T; Neumann J
    Virchows Arch; 2021 Apr; 478(4):695-705. PubMed ID: 33300106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
    Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
    J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Yang S; Zhang D; Sun Q; Nie H; Zhang Y; Wang X; Huang Y; Sun Y
    Cancer Res; 2024 Jul; 84(13):2202-2217. PubMed ID: 38657117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNB1 promotes hepatocellular carcinoma progression by targeting BAG2 to activate P38/MAPK signaling.
    Zhang X; Dong K; Zhang J; Kuang T; Luo Y; Yu J; Yu J; Wang W
    Cancer Sci; 2023 May; 114(5):2001-2013. PubMed ID: 36718954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
    Goos JA; Coupe VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Carvalho B; van den Tol MP; Verheul HM; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Br J Cancer; 2013 Oct; 109(9):2445-52. PubMed ID: 24104968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis.
    Chen D; Sun Q; Cheng X; Zhang L; Song W; Zhou D; Lin J; Wang W
    Cancer Med; 2016 Jul; 5(7):1629-39. PubMed ID: 27165481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
    Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
    Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC14A1 and TGF-β signaling: a feedback loop driving EMT and colorectal cancer metachronous liver metastasis.
    Zhang Y; Yang Y; Qi X; Cui P; Kang Y; Liu H; Wei Z; Wang H
    J Exp Clin Cancer Res; 2024 Jul; 43(1):208. PubMed ID: 39061061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.
    Lopez G; Boggio F; Ferrero S; Fusco N; Del Gobbo A
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C
    Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
    Goos JA; Coupé VM; van de Wiel MA; Diosdado B; Delis-Van Diemen PM; Hiemstra AC; de Cuba EM; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Oncotarget; 2016 Jan; 7(2):2123-34. PubMed ID: 26497206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy.
    Xie J; Wang S
    Technol Cancer Res Treat; 2022; 21():15330338221103318. PubMed ID: 35899305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
    Chen Y; Yu X; Xu Y; Shen H
    Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.